| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.0078 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |